Grants for Small businesses - Federal

This funding opportunity supports researchers at various institutions to investigate how combining vaccine adjuvants can improve immune responses, ultimately leading to better vaccine designs for different diseases.

This grant provides funding for research aimed at understanding the factors that contribute to health disparities in HIV and aging among racial and ethnic minorities, low-income populations, and other underserved groups, focusing on how multiple health conditions affect their overall well-being and quality of life.

The U.S. Department of State, Bureau of Democracy, Human Rights, and Labor (DRL) announces an open competition for organizations interested in submitting applications for projects that increase transparency in citizens’ rights to due process. Uzbekistan’s constitution and law prohibit arbitrary arrest and detention and provide for the right of any person to challenge the lawfulness of his or her arrest or detention in court. Additionally, by law a judge must review any decision to arrest accused individuals or suspects. Judges grant arrest warrants in most cases. Detention without formal charges is limited to 48 hours, although a prosecutors may request that a judge extend detention an additional 48 hours, after which the person must be charged or released. Judges typically grant such requests, and the judge who issues such an extension is often the same one who presided over the trial, which creates incentives to cover up violations. The arresting authority is required to notify a relative of a detainee of the detention and to question the detainee within 24 hours of arrest. Visibility into arrest procedures and treatment of detainees is low, even for family members of detainees and Uzbekistani civil society engaged on the issue of due process. 2 Through this award, DRL aims to support the safe, secure, and professional collection of credible information on political detainees by Uzbekistani media, Civil Society Organizations, (CSOs) and human rights defenders, for human rights reporting and advocacy and to improve the capacity of Uzbekistani CSOs to advocate for transparency and improved conditions in detention facilities.

The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative and revolutionary computational approaches that measure the feasibility of technical claims to enable accurate assessments of scientific content. This publication constitutes a Broad Agency Announcement (BAA) as contemplated in Federal Acquisition Regulation (FAR) 6.102(d)(2) and 35.016 and 2 C.F.R. § 200.203. Any resultant award negotiations will follow all pertinent laws and regulations, and any negotiations and/or awards for procurement contracts will use procedures under FAR 15.4, Contract Pricing, as specified in the BAA. The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative proposals in the following areas of interest: feasibility assessment of scientific content and testing and evaluation of feasibility assessment methods. Proposed research should investigate innovative approaches that enable revolutionary advances in science or systems. Specifically excluded is research that primarily results in evolutionary improvements to the existing state of practice. Multiple awards are anticipated. The amount of resources made available under this BAA will depend on the quality of the proposals received and the availability of funds.

This grant provides funding for innovative technologies that enhance the detection and neutralization of underwater threats, targeting researchers and companies specializing in explosive ordnance disposal and underwater robotics.

USAID/Senegals Sahel Regional Office (USAID/Senegal/SRO) ADDENDUM #1 - CALL FOR CONCEPT PAPERS USAID Strengthening Information Integrity and Resilience (IIR) in the Sahel USAID Sahel Information Integrity Annual Program Statement No. 72068524APS00003 Issuance Date: June 28, 2024 Closing Date: July 30, 2024 Questions Due Date for this APS Addendum: July 9, 2025 Dear Prospective Applicants: This is an Addendum to the USAID Sahel Information Integrity Annual Program Statement (APS) (No.72068524APS00003). All interested organizations should carefully review both this Addendum AND the full APS, which can be found here in grants.gov . Important information contained in the APS announcement is not necessarily repeated in this specific Addendum. This activity is authorized under the Foreign Assistance Act of 1961, as amended. Through this Addendum #1 to APS No. 72068524APS00003, USAID/Senegal/SRO is requesting the submission of concept papers focused on Strengthening Information Integrity and Resilience (IIR) in the Sahel. Concept papers should describe a nimble and adaptive approach for supporting key actors in local and regional information ecosystems to be more effective in advancing information integrity and resilience in their local and regional systems. TARGET COUNTRIES: All three objectives of this activity (as outlined under technical focus below) must be addressed in all of the following countries, which fall under the management authority of USAID/Senegal/SRO: Burkina Faso Chad Mauritania Objective 2 under this APS (which relates to strengthening regional networks) may also create opportunities for partner organizations in Cabo Verde, The Gambia, Guinea-Bissau, Mali, Niger, and Senegal based on prior approval from USAID. Under this Addendum, subject to the availability of funds, USAID anticipates making one award. USAID also reserves the right to make no awards. The total USAID funds anticipated is $15,000,000. USAID contemplates a start date for the award beginning on or about December 1, 2024, with a period of performance of up to five years. Applicants should send general questions about the below information by email to USAID primary and secondary points of contact, Ms. Aminata Diallo, at [email protected] and Robert Almosd at [email protected], respectively. See " related Documents" Tab for the full Addendum Thank you for your interest in USAID Programs. Sincerely,

This funding opportunity provides financial support to shipyards and training organizations to improve the repair capabilities and workforce skills for non-nuclear U.S. Navy vessels.

This grant provides funding to support promising postdoctoral researchers in neuroscience, enabling them to receive advanced training and mentorship in a focused research environment.

Grant Title: Centers on the Demography and Economics of Aging, Including Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) (D and E Centers) (P30 Clinical Trial Optional) aims to support interdisciplinary research centers that focus on the social science aspects of aging, particularly related to health disparities, economic impacts, and caregiving for dementia, while fostering collaboration among diverse scholars and institutions.

This funding opportunity provides financial support to small businesses that previously received Phase I SBIR grants from NIST, enabling them to further develop their innovative projects into commercially viable products or services.

This funding opportunity supports innovative projects that develop advanced high-voltage direct current technologies to enhance the resilience and sustainability of the U.S. energy grid, targeting domestic entities and collaborations focused on improving power transmission systems.

The National Cancer Institute (NCI) intends to issue the U54 Specialized Programs of Research Excellence in Cancer Health Disparities and Minority Health (CHD-MH SPORE) notice of funding opportunity (NOFO). The program will support a network of multidisciplinary, multi-institutional U54 CHD-MH SPOREs, which are multi-project awards uniquely focused on health disparities and/or minority health translational research for improved prevention, early detection, diagnosis, and treatment of cancer in populations who are underserved. U54 CHD-MH SPOREs can investigate more than one cancer type in underserved populations, including groups of highly related cancers (e.g., gastrointestinal or head and neck). The research supported through this program must be translational and must stem from research on human biology, addressing the interplay of various determinants of health with the biology of the disease. U54 CHD-MH SPORE projects must have the goal of reaching a translational human endpoint within the project period of the grant, which may include a clinical trial. This Notice of Intent to Publish is being provided to allow sufficient time for applicants to develop strong applications. The NOFO is expected to be published in late winter 2024 with only one expected application due date in late September 2024.

This grant provides funding for research projects that explore the complex processes of cancer metastasis, encouraging collaboration among institutions to improve understanding and treatment of metastatic diseases.

This funding opportunity supports research on policies affecting tobacco, alcohol, and cannabis use in underserved communities, aiming to promote health equity and reduce disparities in substance exposure and use.

This funding opportunity provides financial support for research aimed at improving the spread and implementation of effective health interventions, particularly in underserved communities, with a focus on promoting health equity and addressing health disparities.

This funding opportunity supports small businesses in developing innovative, non-addictive therapies and technologies for effective pain management, addressing the urgent need for alternatives to opioid treatments.

This funding opportunity provides financial support for organizations to host conferences and workshops that promote research integrity and ethical practices in research across various disciplines.

This funding opportunity provides financial support to local organizations in Zimbabwe to implement comprehensive HIV prevention and treatment programs, focusing on key populations and improving health services to achieve and maintain epidemic control.

This funding opportunity supports the establishment of research centers that create advanced animal models for studying diseases, enabling better translation of genetic research into human health applications, and is open to a variety of eligible institutions and organizations.

This funding opportunity supports innovative research projects focused on developing and testing radionuclide-based cancer therapies, particularly in preclinical settings, to improve treatment outcomes and understanding of their effects on tumors and normal tissues.